drugset / Trial / NCT02569853
DFN-11 Injection in Episodic Migraine With or Without Aura
RandomizedParallel-groupDouble-blindTreatment
Summary
Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.
Timeline
- Start
- 2015-09-21
- Primary completion
- 2017-05-30
- Completion
- 2018-02-26
Publications
- Landy S, Munjal S, Brand-Schieber E, Rapoport AM. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study. J Headache Pain. 2018 Aug 15;19(1):69. doi: 10.1186/s10194-018-0881-z.
- Landy S, Munjal S, Brand-Schieber E, Rapoport AM. Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: an 8-week open-label extension study. J Headache Pain. 2018 Aug 15;19(1):70. doi: 10.1186/s10194-018-0882-y.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sumatriptan | Unknown | 3 mg | Subcutaneous |